Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 3 studies | 20% ± 5% | |
dendritic cell | 3 studies | 34% ± 9% |
Insufficient scRNA-seq data for expression of NAGPA at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 601.93 | 226 / 226 | 100% | 11.18 | 406 / 406 |
stomach | 100% | 974.74 | 359 / 359 | 100% | 11.64 | 286 / 286 |
skin | 100% | 928.48 | 1808 / 1809 | 100% | 16.03 | 472 / 472 |
esophagus | 100% | 757.50 | 1443 / 1445 | 100% | 8.62 | 183 / 183 |
intestine | 100% | 1076.81 | 965 / 966 | 100% | 11.99 | 526 / 527 |
thymus | 100% | 880.74 | 652 / 653 | 100% | 10.07 | 604 / 605 |
kidney | 100% | 995.17 | 89 / 89 | 100% | 10.96 | 898 / 901 |
brain | 100% | 1557.93 | 2633 / 2642 | 100% | 8.82 | 705 / 705 |
prostate | 100% | 877.73 | 245 / 245 | 100% | 9.68 | 500 / 502 |
uterus | 100% | 782.29 | 170 / 170 | 99% | 9.77 | 456 / 459 |
ovary | 99% | 526.87 | 179 / 180 | 100% | 7.89 | 429 / 430 |
breast | 100% | 754.34 | 459 / 459 | 99% | 8.87 | 1109 / 1118 |
adrenal gland | 100% | 884.97 | 257 / 258 | 99% | 10.01 | 228 / 230 |
bladder | 100% | 852.52 | 21 / 21 | 99% | 10.17 | 497 / 504 |
lung | 98% | 802.49 | 569 / 578 | 100% | 9.64 | 1152 / 1155 |
pancreas | 98% | 431.63 | 323 / 328 | 99% | 9.58 | 177 / 178 |
adipose | 100% | 795.51 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 12.09 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 14.49 | 29 / 29 |
spleen | 100% | 1608.37 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 10.29 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.31 | 1 / 1 |
blood vessel | 99% | 591.95 | 1322 / 1335 | 0% | 0 | 0 / 0 |
muscle | 98% | 413.89 | 785 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 647.26 | 898 / 929 | 0% | 0 | 0 / 0 |
heart | 95% | 404.90 | 815 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007040 | Biological process | lysosome organization |
GO_0033299 | Biological process | secretion of lysosomal enzymes |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0036211 | Biological process | protein modification process |
GO_0006622 | Biological process | protein targeting to lysosome |
GO_0006486 | Biological process | protein glycosylation |
GO_0032580 | Cellular component | Golgi cisterna membrane |
GO_0016020 | Cellular component | membrane |
GO_0003944 | Molecular function | N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | NAGPA |
Protein name | N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase (EC 3.1.4.45) (Mannose 6-phosphate-uncovering enzyme) (Phosphodiester alpha-GlcNAcase) N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase |
Synonyms | |
Description | FUNCTION: Catalyzes the second step in the formation of the mannose 6-phosphate targeting signal on lysosomal enzyme oligosaccharides by removing GlcNAc residues from GlcNAc-alpha-P-mannose moieties, which are formed in the first step. Also hydrolyzes UDP-GlcNAc, a sugar donor for Golgi N-acetylglucosaminyltransferases. . |
Accessions | ENST00000381955.7 [Q9UK23-2] ENST00000562037.1 K7EL75 K7EPH3 K7EK96 ENST00000565876.5 Q9UK23 ENST00000649828.1 [Q9UK23-3] ENST00000312251.8 [Q9UK23-1] ENST00000562746.5 [Q9UK23-3] K7EJ25 ENST00000563578.5 ENST00000569296.5 K7ERI4 ENST00000562346.2 |